The University of Chicago Header Logo

Samuel Volchenboum

Concepts (352)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neuroblastoma
25
2026
410
3.890
Why?
Medical Oncology
11
2026
426
2.900
Why?
Neoplasms
20
2026
3382
2.220
Why?
Electronic Health Records
7
2026
456
1.780
Why?
Information Dissemination
9
2026
135
1.410
Why?
Pediatrics
6
2026
422
1.390
Why?
Natural Language Processing
2
2023
44
1.310
Why?
Child
37
2026
7771
1.270
Why?
Clinical Trials as Topic
3
2024
1128
1.080
Why?
Medical Informatics
4
2021
51
1.020
Why?
Databases, Factual
8
2025
1102
0.960
Why?
Trees
1
2025
48
0.870
Why?
Protein Processing, Post-Translational
3
2015
404
0.780
Why?
Software
4
2019
698
0.750
Why?
Pathology, Molecular
2
2019
36
0.720
Why?
Humans
78
2026
98799
0.660
Why?
Leukemia
1
2023
310
0.660
Why?
Biomedical Research
4
2025
477
0.650
Why?
Health Services Accessibility
1
2025
548
0.620
Why?
Research Report
2
2021
43
0.620
Why?
Asthma
2
2025
1083
0.600
Why?
Heuristics
1
2019
15
0.590
Why?
Rhabdomyosarcoma
3
2025
44
0.580
Why?
Radionuclide Imaging
2
2021
183
0.580
Why?
Child, Preschool
17
2026
4053
0.550
Why?
Soft Tissue Neoplasms
3
2025
127
0.550
Why?
Infant
19
2026
3368
0.540
Why?
Gene Expression Profiling
3
2013
1572
0.490
Why?
Hospital Units
1
2016
29
0.490
Why?
Genomics
6
2026
914
0.480
Why?
Pharmacogenetics
4
2025
474
0.480
Why?
Emergencies
1
2016
126
0.470
Why?
Management Information Systems
1
2016
3
0.470
Why?
Adolescent
19
2026
10168
0.460
Why?
Patient Transfer
1
2016
116
0.450
Why?
Pressure Ulcer
1
2016
45
0.450
Why?
Biomarkers, Tumor
5
2022
1786
0.440
Why?
Precision Medicine
6
2026
512
0.430
Why?
Telemedicine
1
2018
256
0.430
Why?
Polysaccharides
1
2015
101
0.420
Why?
Image Interpretation, Computer-Assisted
1
2018
645
0.410
Why?
Patient Care Team
1
2016
318
0.400
Why?
Paired Box Transcription Factors
1
2013
50
0.390
Why?
Heart Arrest
1
2016
315
0.380
Why?
Critical Care
1
2016
464
0.380
Why?
Oxidoreductases Acting on CH-CH Group Donors
3
2001
11
0.360
Why?
Lysine
2
2011
170
0.360
Why?
Forkhead Transcription Factors
1
2013
185
0.360
Why?
Algorithms
4
2019
2005
0.350
Why?
Proteomics
5
2016
282
0.350
Why?
Oxidoreductases
3
2001
112
0.350
Why?
Neoplasms, Germ Cell and Embryonal
2
2022
64
0.320
Why?
Loss of Heterozygosity
2
2014
85
0.320
Why?
3-Iodobenzylguanidine
2
2021
20
0.310
Why?
Patient Selection
2
2024
725
0.300
Why?
Registries
3
2026
1133
0.300
Why?
Young Adult
13
2026
7598
0.290
Why?
Isotope Labeling
1
2009
54
0.290
Why?
Databases, Protein
1
2009
52
0.290
Why?
Computational Biology
2
2015
620
0.280
Why?
Machine Learning
3
2022
413
0.270
Why?
Polymorphism, Single Nucleotide
3
2019
2577
0.260
Why?
N-Myc Proto-Oncogene Protein
3
2017
41
0.260
Why?
Genetic Predisposition to Disease
5
2026
2588
0.260
Why?
Artificial Intelligence
2
2024
489
0.260
Why?
Age Factors
4
2021
1976
0.260
Why?
Patient-Centered Care
2
2023
233
0.250
Why?
Male
21
2026
47475
0.250
Why?
Cohort Studies
9
2021
3242
0.250
Why?
Female
22
2026
51997
0.240
Why?
High-Throughput Nucleotide Sequencing
2
2022
588
0.230
Why?
Congenital Abnormalities
1
2026
69
0.230
Why?
Biological Specimen Banks
1
2026
83
0.230
Why?
Rare Diseases
1
2026
75
0.230
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2026
54
0.230
Why?
Reproducibility of Results
5
2018
2799
0.220
Why?
Patient Portals
1
2025
36
0.210
Why?
Acyl Coenzyme A
2
2001
17
0.210
Why?
Gene Amplification
2
2017
142
0.210
Why?
Sarcoma
2
2025
222
0.210
Why?
Data Mining
1
2024
45
0.210
Why?
Hematology
1
2024
37
0.200
Why?
Proteins
1
2009
804
0.200
Why?
Prognosis
9
2024
4139
0.200
Why?
Neoplasms, Second Primary
2
2016
244
0.200
Why?
Hodgkin Disease
1
2024
144
0.190
Why?
Amino Acid Metabolism, Inborn Errors
2
2000
11
0.190
Why?
Oncogene Proteins
2
2015
66
0.190
Why?
Eligibility Determination
1
2023
42
0.190
Why?
Gene Expression Regulation
1
2011
2023
0.190
Why?
Residence Characteristics
1
2025
240
0.190
Why?
Pharmacogenomic Testing
2
2025
119
0.190
Why?
Immunologic Deficiency Syndromes
1
2022
38
0.180
Why?
Rhabdomyosarcoma, Embryonal
1
2022
7
0.180
Why?
Socioeconomic Factors
1
2025
675
0.180
Why?
Genome-Wide Association Study
2
2017
1863
0.180
Why?
Disease Progression
2
2025
1621
0.180
Why?
Chromatography, Liquid
2
2015
102
0.180
Why?
Chicago
2
2025
1520
0.180
Why?
Mutation
4
2015
4443
0.180
Why?
Data Collection
2
2023
376
0.170
Why?
Testicular Neoplasms
1
2022
126
0.170
Why?
Cell Line, Tumor
5
2015
2913
0.170
Why?
User-Computer Interface
2
2019
195
0.170
Why?
Arginine
1
2001
144
0.170
Why?
Whole Genome Sequencing
1
2021
121
0.170
Why?
Neoplasm Staging
4
2020
2087
0.160
Why?
Multiple Myeloma
2
2015
372
0.160
Why?
Adult
12
2025
29698
0.160
Why?
Substrate Specificity
1
2001
373
0.160
Why?
Risk Factors
9
2026
6295
0.160
Why?
Prospective Studies
6
2026
4837
0.160
Why?
Alzheimer Disease
1
2026
649
0.160
Why?
Public Health Surveillance
1
2020
24
0.150
Why?
Survivorship
1
2020
27
0.150
Why?
Myeloablative Agonists
2
2016
38
0.150
Why?
Oligonucleotide Array Sequence Analysis
2
2013
700
0.150
Why?
Decision Support Systems, Clinical
2
2017
135
0.140
Why?
Remote Sensing Technology
1
2018
10
0.140
Why?
Workflow
1
2019
88
0.140
Why?
Nuclear Proteins
2
2015
757
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2021
2666
0.140
Why?
Neoplasm Recurrence, Local
3
2022
1538
0.140
Why?
Biomedical Technology
1
2018
27
0.140
Why?
Research
1
2020
258
0.140
Why?
Infant, Newborn
5
2026
2556
0.140
Why?
Survivors
2
2016
211
0.140
Why?
Smartphone
1
2018
55
0.140
Why?
Database Management Systems
1
2018
44
0.130
Why?
Wearable Electronic Devices
1
2018
47
0.130
Why?
Diabetes Mellitus
1
2025
815
0.130
Why?
Medical Order Entry Systems
1
2017
29
0.130
Why?
Radiopharmaceuticals
1
2018
214
0.130
Why?
Coronary Care Units
1
2016
5
0.130
Why?
Survival Analysis
3
2021
1530
0.120
Why?
Tumor Microenvironment
1
2021
621
0.120
Why?
Fallopian Tube Neoplasms
1
2016
39
0.120
Why?
Buthionine Sulfoximine
1
2016
7
0.120
Why?
Point-of-Care Systems
1
2017
155
0.120
Why?
Caspase 10
1
2015
5
0.120
Why?
Melphalan
1
2016
98
0.120
Why?
Cystadenocarcinoma, Serous
1
2016
69
0.120
Why?
Hydrazines
1
2015
36
0.110
Why?
Mitochondria
1
2000
653
0.110
Why?
Neoplasms, Glandular and Epithelial
1
2016
81
0.110
Why?
Drug Prescriptions
1
2017
161
0.110
Why?
Antineoplastic Agents, Alkylating
1
2016
136
0.110
Why?
Physician's Role
1
2017
183
0.110
Why?
Carbohydrate Sequence
1
2015
18
0.110
Why?
Spectrometry, Mass, Electrospray Ionization
1
2015
23
0.110
Why?
Molecular Sequence Data
2
2015
2897
0.110
Why?
Proteome
1
2016
165
0.110
Why?
Triazoles
1
2015
118
0.110
Why?
Ribonucleoside Diphosphate Reductase
1
2014
7
0.110
Why?
Immunotherapy
1
2021
831
0.110
Why?
Peritoneal Neoplasms
1
2016
196
0.110
Why?
Odds Ratio
1
2016
728
0.110
Why?
Glycosylation
1
2015
142
0.110
Why?
Hematopoietic Stem Cells
2
2016
330
0.110
Why?
Exome
1
2015
150
0.110
Why?
Antimetabolites, Antineoplastic
1
2016
246
0.110
Why?
Plasma Cells
1
2015
93
0.100
Why?
HSP90 Heat-Shock Proteins
1
2014
45
0.100
Why?
Oligopeptides
1
2015
205
0.100
Why?
Computer Communication Networks
1
2014
24
0.100
Why?
Skull
1
2016
280
0.100
Why?
Anticoagulants
2
2019
486
0.100
Why?
Protein Conformation
2
2011
933
0.100
Why?
DNA Repair
2
2016
363
0.100
Why?
Risk Assessment
4
2022
2604
0.100
Why?
HSP70 Heat-Shock Proteins
1
2014
119
0.100
Why?
Adenosine Triphosphatases
1
2014
142
0.100
Why?
Critical Illness
1
2016
364
0.100
Why?
Neurocalcin
1
2013
2
0.100
Why?
Forkhead Box Protein O1
1
2013
30
0.100
Why?
Patient Discharge
1
2016
385
0.100
Why?
Citric Acid
1
2013
47
0.100
Why?
Radiation Injuries
1
2014
160
0.100
Why?
Sex Factors
1
2016
1144
0.100
Why?
Inpatients
1
2016
371
0.100
Why?
Cell Separation
1
2013
201
0.090
Why?
Research Design
2
2026
652
0.090
Why?
Middle Aged
5
2025
29642
0.090
Why?
Sequence Analysis, DNA
1
2016
920
0.090
Why?
Isovaleryl-CoA Dehydrogenase
3
2001
3
0.090
Why?
Heparin
1
2013
182
0.090
Why?
DNA Damage
1
2014
400
0.090
Why?
Radiotherapy
1
2014
325
0.090
Why?
Enzyme Stability
3
2001
49
0.090
Why?
Hematopoietic Stem Cell Transplantation
2
2016
979
0.090
Why?
Gene Expression Regulation, Neoplastic
2
2017
1400
0.090
Why?
Germ-Line Mutation
1
2015
404
0.090
Why?
Pelvic Neoplasms
1
2012
43
0.090
Why?
Saccharomyces cerevisiae Proteins
1
2014
310
0.090
Why?
Acetylation
1
2011
151
0.090
Why?
Ubiquitin
1
2011
95
0.080
Why?
Saccharomyces cerevisiae
1
2014
480
0.080
Why?
Aged, 80 and over
2
2019
7461
0.080
Why?
Gene Expression
1
2015
1322
0.080
Why?
Protein Structure, Secondary
1
2011
342
0.080
Why?
Disease-Free Survival
3
2021
1196
0.080
Why?
Methylation
1
2011
294
0.080
Why?
Time Factors
2
2016
5586
0.080
Why?
Survival Rate
3
2024
2057
0.080
Why?
Combined Modality Therapy
2
2016
1754
0.080
Why?
Leukemia, Myeloid, Acute
1
2016
850
0.080
Why?
Lymph Nodes
1
2014
563
0.080
Why?
Protein Structure, Tertiary
1
2011
733
0.080
Why?
Cell Cycle
1
2011
519
0.080
Why?
Ovarian Neoplasms
1
2016
829
0.080
Why?
Brain Neoplasms
1
2016
845
0.070
Why?
Homeodomain Proteins
1
2013
568
0.070
Why?
Apoptosis
1
2015
1754
0.070
Why?
Aged
4
2025
21986
0.070
Why?
Erythrocyte Transfusion
1
2010
82
0.070
Why?
Chromosomes, Human, Pair 11
1
2009
106
0.070
Why?
Chromosomes, Human, Pair 15
1
2009
66
0.070
Why?
Phosphorylation
1
2011
1148
0.070
Why?
Chromosomes, Human, Pair 14
1
2009
52
0.070
Why?
Cell Line
2
2013
2484
0.070
Why?
Chromosomes, Human, Pair 1
1
2009
107
0.070
Why?
Isoantibodies
1
2010
138
0.070
Why?
Autoantibodies
1
2010
286
0.070
Why?
Mass Spectrometry
1
2009
189
0.070
Why?
Information Storage and Retrieval
1
2009
129
0.070
Why?
Ecosystem
2
2023
425
0.070
Why?
DNA, Neoplasm
1
2009
267
0.070
Why?
Stromal Cells
1
2009
153
0.070
Why?
Antineoplastic Agents
3
2024
2386
0.070
Why?
Chromosome Aberrations
1
2009
353
0.070
Why?
Anemia, Sickle Cell
1
2010
158
0.060
Why?
Neoplasm Metastasis
3
2016
1102
0.060
Why?
Peptide Fragments
1
2009
480
0.060
Why?
Clinical Trials, Phase I as Topic
1
2008
154
0.060
Why?
Models, Molecular
2
2001
1397
0.060
Why?
Chromosome Mapping
1
2009
1064
0.060
Why?
United States
3
2026
8387
0.060
Why?
Multicenter Studies as Topic
1
2026
195
0.060
Why?
North America
1
2026
211
0.060
Why?
Drug Synergism
2
2016
317
0.060
Why?
Transcription Factors
1
2013
1724
0.050
Why?
Gene-Environment Interaction
1
2026
125
0.050
Why?
Mice
3
2016
12762
0.050
Why?
Treatment Outcome
4
2025
9806
0.050
Why?
Models, Biological
1
2011
1806
0.050
Why?
Genotype
1
2009
1895
0.050
Why?
Health Information Interoperability
1
2024
13
0.050
Why?
Protein Binding
2
2013
1564
0.050
Why?
National Cancer Institute (U.S.)
1
2023
77
0.050
Why?
Patient Participation
1
2025
251
0.050
Why?
Follow-Up Studies
2
2024
4049
0.050
Why?
Recombinant Proteins
2
2001
994
0.040
Why?
Genetic Testing
1
2026
610
0.040
Why?
Early Diagnosis
1
2022
141
0.040
Why?
Molecular Diagnostic Techniques
1
2022
74
0.040
Why?
Africa
1
2022
114
0.040
Why?
Retrospective Studies
3
2024
11104
0.040
Why?
Energy Transfer
1
2001
25
0.040
Why?
Spectrometry, Fluorescence
1
2001
83
0.040
Why?
Incidence
2
2016
1798
0.040
Why?
Amino Acid Substitution
1
2001
336
0.040
Why?
Research Subjects
1
2021
80
0.040
Why?
Mitotic Index
1
2020
22
0.040
Why?
Hemiterpenes
1
2000
6
0.040
Why?
Pentanoic Acids
1
2000
7
0.040
Why?
Leucine
1
2000
57
0.040
Why?
Animals
4
2016
29045
0.040
Why?
Mitosis
1
2020
152
0.040
Why?
Bayes Theorem
1
2021
423
0.040
Why?
Open Reading Frames
1
2000
118
0.040
Why?
Molecular Targeted Therapy
1
2022
331
0.040
Why?
Sequence Homology, Amino Acid
1
2000
403
0.040
Why?
Biological Transport
1
2000
402
0.040
Why?
Warfarin
1
2019
109
0.040
Why?
Proportional Hazards Models
1
2021
925
0.040
Why?
Binding Sites
1
2001
1162
0.030
Why?
Neoplasm Grading
1
2020
425
0.030
Why?
Drug Labeling
1
2017
44
0.030
Why?
Durapatite
1
2016
36
0.030
Why?
Amino Acid Sequence
1
2000
2011
0.030
Why?
Glutamate-Cysteine Ligase
1
2016
6
0.030
Why?
Genomic Instability
1
2016
92
0.030
Why?
Caspase 8
1
2015
32
0.030
Why?
Intracellular Space
1
2015
38
0.030
Why?
Glutathione
1
2016
108
0.030
Why?
Proteasome Inhibitors
1
2015
52
0.030
Why?
Cost of Illness
1
2016
165
0.030
Why?
Gene Frequency
1
2017
716
0.030
Why?
Pandemics
1
2021
923
0.030
Why?
Diffusion of Innovation
1
2015
81
0.030
Why?
Genetic Association Studies
1
2016
317
0.030
Why?
International Cooperation
1
2015
133
0.030
Why?
Bortezomib
1
2015
83
0.030
Why?
Boronic Acids
1
2015
56
0.030
Why?
Tumor Cells, Cultured
1
2016
1029
0.030
Why?
Thalidomide
1
2015
57
0.030
Why?
Interdisciplinary Communication
1
2015
137
0.030
Why?
DNA, Fungal
1
2014
61
0.030
Why?
Pyrazines
1
2015
98
0.030
Why?
Enzyme Activation
1
2015
679
0.030
Why?
Medical Record Linkage
1
2014
16
0.030
Why?
Computer Security
1
2014
18
0.030
Why?
Age of Onset
1
2015
369
0.030
Why?
Information Systems
1
2014
29
0.030
Why?
Doxorubicin
1
2015
285
0.030
Why?
Confidentiality
1
2014
77
0.030
Why?
Cooperative Behavior
1
2015
199
0.030
Why?
Xenograft Model Antitumor Assays
1
2015
559
0.030
Why?
Autophagy
1
2015
176
0.020
Why?
Biomarkers
1
2020
2026
0.020
Why?
SEER Program
1
2014
252
0.020
Why?
Dexamethasone
1
2015
318
0.020
Why?
Protein Interaction Maps
1
2013
54
0.020
Why?
Case-Control Studies
1
2017
2017
0.020
Why?
Polyethylene Glycols
1
2015
383
0.020
Why?
Internet
1
2015
359
0.020
Why?
Cytoplasm
1
2013
276
0.020
Why?
Transcriptional Activation
1
2013
293
0.020
Why?
Lymphatic Metastasis
1
2014
519
0.020
Why?
Neoplasm Proteins
1
2014
553
0.020
Why?
HEK293 Cells
1
2013
724
0.020
Why?
Cell Nucleus
1
2013
616
0.020
Why?
Predictive Value of Tests
1
2015
1792
0.020
Why?
Phylogeny
1
2016
1344
0.020
Why?
Laryngeal Edema
1
2010
7
0.020
Why?
Hemagglutinins
1
2010
22
0.020
Why?
Promoter Regions, Genetic
1
2013
979
0.020
Why?
Death, Sudden
1
2010
43
0.020
Why?
Acute Chest Syndrome
1
2010
22
0.020
Why?
Peptides
1
2013
671
0.020
Why?
Immunization
1
2010
154
0.020
Why?
Liver Neoplasms
1
2016
840
0.020
Why?
Herpes Simplex
1
2010
79
0.020
Why?
Fatal Outcome
1
2010
295
0.020
Why?
Calcium
1
2013
1205
0.020
Why?
Disease Models, Animal
1
2015
2581
0.020
Why?
Cell Differentiation
1
2013
1656
0.020
Why?
Drug Administration Schedule
1
2008
837
0.010
Why?
Diagnosis, Differential
1
2010
1571
0.010
Why?
Pneumonia, Viral
1
2010
343
0.010
Why?
Breast Neoplasms
1
2014
3303
0.010
Why?
Mitochondria, Liver
1
1998
29
0.010
Why?
Spectrophotometry
1
1998
102
0.010
Why?
DNA, Complementary
1
1998
380
0.010
Why?
Crystallography, X-Ray
1
1998
532
0.010
Why?
DNA Mutational Analysis
1
1998
554
0.010
Why?
Kinetics
1
1998
1478
0.010
Why?
Rats, Sprague-Dawley
1
1998
1256
0.010
Why?
Escherichia coli
1
1998
572
0.010
Why?
Fibroblasts
1
1998
767
0.010
Why?
Cells, Cultured
1
1998
2859
0.010
Why?
Rats
1
1998
4079
0.010
Why?
Volchenboum's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (352)
Explore
_
Co-Authors (58)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_